The companies building AI products in 2026 face a marketing reality that the companies building software in 2020 didn’t: their potential customers increasingly find them through other AI systems, not through traditional search. A founder evaluating which computer vision platform to integrate doesn’t necessarily start with a Google search. They ask ChatGPT. They consult Perplexity. […]
Source: MrrTrack model
Estimated active users × assumed paying share × estimated monthly revenue per customer. We distinguish B2B, B2C and creator tools, and use comparable revenue when available. These are model assumptions, not measured sales.
Indicative range $105–$1.4k
Share of monthly visits
Map unavailable. Country shares are listed alongside.
Geographic breakdown unavailable.
The companies building AI products in 2026 face a marketing reality that the companies building software in 2020 didn’t: their potential customers increasingly find them through other AI systems, not through traditional search. A founder evaluating which computer vision platform to integrate doesn’t necessarily start with a Google search. They ask ChatGPT. They consult Perplexity. […]
Share of monthly visits
Updated: 09/01/2026
Traffic, revenue and acquisition: the data behind the product.
Catalog updated on
The companies building AI products in 2026 face a marketing reality that the companies building software in 2020 didn’t: their potential customers increasingly find them through other AI systems, not through traditional search. A founder evaluating which computer vision platform to integrate doesn’t necessarily start with a Google search. They ask ChatGPT. They consult Perplexity. […]
Official website kogniz.comKogniz Vaccine Test Management receives an estimated 1,024 visits in September 2026.
This represents a change of +1,728.6% compared with August 2026 (56 visits).
These are estimated visits, not unique users or paying customers. Traffic growth does not establish sales growth.
| Month | Visits |
|---|---|
| 1,347 | |
| 56 | |
| 1,024 |
Kogniz Vaccine Test Management has an estimated monthly revenue of $380. This is an estimate, not company-reported revenue or payment-verified MRR.The model uses available product, traffic and comparable SaaS signals; its assumptions remain uncertain.
A geographic breakdown of visits to Kogniz Vaccine Test Management is not available. These shares describe website traffic, not the location of paying customers.
The recorded channels include: Direct (38.5%), Search (37.9%), Referrals (8.9%).Coverage may be partial: a missing value does not establish that a channel is unused. These visits do not measure conversions or advertising returns.
The YouTube and Meta Ads sections let you explore collected mentions and creatives. Access depends on your account and subscription.
Explore acquisition dataThe selection of SaaS to compare includes Georankers, Thecompaniesapi, Knowatoa, Getaiso.Similarity is assessed from available descriptions, categories and use cases. It does not guarantee equivalent features or pricing.
Answers based on the data available in this profile.
Kogniz Vaccine Test Management receives an estimated 1,024 visits in September 2026. These are estimated visits, not unique users or paying customers. Traffic growth does not establish sales growth.
Kogniz Vaccine Test Management has an estimated monthly revenue of $380. This is an estimate, not company-reported revenue or payment-verified MRR.The model uses available product, traffic and comparable SaaS signals; its assumptions remain uncertain.
This represents a change of +1,728.6% compared with August 2026 (56 visits). These are estimated visits, not unique users or paying customers. Traffic growth does not establish sales growth.
A geographic breakdown of visits to Kogniz Vaccine Test Management is not available. These shares describe website traffic, not the location of paying customers.
The selection of SaaS to compare includes Georankers, Thecompaniesapi, Knowatoa, Getaiso.Similarity is assessed from available descriptions, categories and use cases. It does not guarantee equivalent features or pricing.
The catalog data was last updated on October 26, 2026.The latest available traffic month is September 2026.Traffic periods, collection dates and revenue source dates can differ.
Matched by what the product does. Traffic only breaks ties.
IN
46,2%
US
43,3%
FR
10,5%
$470
Share calculated from Meta's reported reach breakdown. Spend by country is not published.
